Related Experiment Video
Updated: Jun 4, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
[Liver Cirrhosis: ancient disease, new challenge]
Adrià Juanola1, Elisa Pose1, Pere Ginès2
1Servicio de Hepatología, Hospital Clínic de Barcelona, Barcelona, España; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalunya, España; Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, España.
Liver cirrhosis, a major cause of death, stems from alcohol and metabolic liver disease. Eliminating the cause can reverse complications, improving patient outcomes.
Area of Science:
- Hepatology
- Gastroenterology
- Internal Medicine
Background:
- Liver cirrhosis is a significant global health issue contributing to morbidity and mortality.
- Key etiological factors include excessive alcohol consumption and metabolic-associated steatotic liver disease.
- Cirrhosis presents in compensated and decompensated phases, distinguished by the presence of complications.
Purpose of the Study:
- To provide an updated review of liver cirrhosis epidemiology and causes.
- To summarize clinical features and treatment of cirrhosis complications.
- To outline future research directions in liver cirrhosis.
Main Methods:
- Literature review of epidemiological data.
- Synthesis of current knowledge on cirrhosis etiology and pathogenesis.
- Overview of established and emerging therapeutic strategies.
- Analysis of clinical manifestations and management of complications.
Main Results:
- Excessive alcohol and metabolic-associated steatotic liver disease are primary drivers of cirrhosis in the region.
- Management focuses on controlling complications like ascites, encephalopathy, infections, and hemorrhage, or liver transplantation.
- Eliminating the etiological factor can lead to disease recompensation, resolving complications.
Conclusions:
- Understanding cirrhosis epidemiology and etiology is crucial for effective management.
- Targeting etiological factors offers a pathway to disease recompensation.
- Further research is needed to advance treatment and prevention strategies for liver cirrhosis.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Esophageal Varices-I: Introduction
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

